Citation: J. Hogel et al., RANDOMIZED OBSERVATIONAL STUDIES ON THE ECONOMICS OF THERAPIES - BIOMETRICAL EXPERIENCE OF 2 TRIALS, Methods of information in medicine, 37(1), 1998, pp. 53-58
Citation: Ac. Rodloff et al., COMPARATIVE-STUDY OF THE COST-EFFECTIVENESS OF INITIAL THERAPY WITH IMIPENEM CILASTATIN IN SECONDARY PERITONITIS/, Chirurg, 69(10), 1998, pp. 1093-1099
Authors:
LOTTERER E
HOGEL J
GAUS W
FLEIG WE
BIRCHER J
Citation: E. Lotterer et al., QUANTITATIVE LIVER-FUNCTION TESTS AS SURROGATE MARKERS FOR END-POINTSIN CONTROLLED CLINICAL-TRIALS - A RETROSPECTIVE FEASIBILITY STUDY, Hepatology, 26(6), 1997, pp. 1426-1433
Authors:
HUNZELMANN N
ANDERS S
FIERLBECK G
HEIN R
HERRMANN K
ALBRECHT M
BELL S
MUCHE R
WEHNERCAROLI J
GAUS W
KRIEG T
Citation: N. Hunzelmann et al., DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF INTRALESIONAL INTERFERON-GAMMA FOR THE TREATMENT OF LOCALIZED SCLERODERMA, Journal of the American Academy of Dermatology, 36(3), 1997, pp. 433-435
Authors:
UHL W
MALFERTHEINER P
ADLER G
BRUCH HP
LANKISCH PG
LORENZ D
GAUS W
BEGER HG
BUCHLER MW
Citation: W. Uhl et al., A RANDOMIZED CONTROLLED MULTICENTRIC TRIAL ON THE ROLE OF OCTREOTIDE IN HUMAN ACUTE-PANCREATITIS, Gastroenterology, 112(4), 1997, pp. 488-488
Authors:
HUNZELMANN N
ANDERS S
FIERLBECK G
HEIN R
HERRMANN K
ALBRECHT M
BELL S
THUR J
MUCHE R
ADELMANNGRILL B
WEHNERCAROLI J
GAUS W
KRIEG T
Citation: N. Hunzelmann et al., SYSTEMIC SCLERODERMA - MULTICENTER TRIAL OF 1-YEAR OF TREATMENT WITH RECOMBINANT INTERFERON-GAMMA, Archives of dermatology, 133(5), 1997, pp. 609-613
Authors:
HEMMER CJ
HORT G
CHIWAKATA CB
SEITZ R
EGBRING R
GAUS W
HOGEL J
HASSEMER M
NAWROTH PP
KERN P
DIETRICH M
Citation: Cj. Hemmer et al., SUPPORTIVE PENTOXIFYLLINE IN FALCIPARUM-MALARIA - NO EFFECT ON TUMOR-NECROSIS-FACTOR-ALPHA LEVELS OR CLINICAL OUTCOME - A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED STUDY, The American journal of tropical medicine and hygiene, 56(4), 1997, pp. 397-403
Authors:
PORZSOLT F
WOLPL CP
RIST CE
KOSA R
BUCHELE G
GAUS W
Citation: F. Porzsolt et al., COMPARISON OF 3 INSTRUMENTS (QLQ-C30, SF-36, QWB-7) MEASURING HEALTH-RELATED QUALITY-OF-LIFE QUALITY OF WELL-BEING, Psycho-oncology, 5(2), 1996, pp. 103-117
Authors:
PORZSOLT F
WIRTH A
MAYERSTEINACKER R
SCHULTE M
NEGRI G
SUHR P
LINK KH
GAUS W
ROTTINGER EM
Citation: F. Porzsolt et al., QUALITY ASSURANCE BY SPECIFICATION AND ACHIEVEMENT OF GOALS IN PALLIATIVE CANCER-TREATMENT, Cancer treatment reviews, 22, 1996, pp. 41-49
Citation: Mm. Buchler et W. Gaus, RANDOMIZED CONTROLLED MULTICENTER STUDY OF THE PREVENTION OF COMPLICATIONS BY OCTREOTIDE IN PATIENTS UNDERGOING SURGERY FOR CHRONIC-PANCREATITIS - REPLY, British Journal of Surgery, 83(3), 1996, pp. 422-423
Authors:
HEIL G
HERRMANN F
HOELZER D
SEIPELT G
EDER M
HUBER C
KOLBE K
MERTELSMANN R
LINDEMANN A
FRISCH J
NICOLAY C
GAUS W
HEIMPEL H
Citation: G. Heil et al., GM-CSF PRIMING IN THE THERAPY OF DE-NOVO AML PATIENTS - AN UPDATE OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED, Blood, 88(10), 1996, pp. 828-828
Citation: W. Gaus, UNILATERAL ABOVE-KNEE AMPUTATION AND ABDO MINAL AORTIC-ANEURYSM - VIEWPOINT OF THE BIOMETRICIAN, Deutsche Medizinische Wochenschrift, 120(22), 1995, pp. 817-818
Authors:
HEIL G
MITROU PS
HOELZER D
FREUND M
LINK H
EHNINGER G
STEINKE B
OHL S
WANDT H
FACKLERSCHWALBE E
SCHLIMOK G
LOSCH A
QUEISSER W
LOFFLER B
GAUS W
HOGEL J
HEIMPEL H
KURRLE E
Citation: G. Heil et al., HIGH-DOSE CYTOSINE-ARABINOSIDE AND DAUNORUBICIN POSTREMISSION THERAPYIN ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA - LONG-TERM FOLLOW-UP OF A PROSPECTIVE MULTICENTER TRIAL, Annals of hematology, 71(5), 1995, pp. 219-225
Authors:
HEIL G
CHADID L
HOELZER D
SEIPELT G
MITROU P
HUBER C
KOLBE K
MERTELSMANN R
LINDEMANN A
FRISCH J
NICOLAY U
GAUS W
HEIMPEL H
Citation: G. Heil et al., GM-CSF IN A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN THERAPY OF ADULT PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML), Leukemia, 9(1), 1995, pp. 3-9
Authors:
HUNZELMANN N
ANDERS S
FIERLBECK G
HEIN R
HERMANN K
ALBRECHT M
BELLBRANDT S
MUCHE R
WEHNERCAROLL J
GAUS W
KRIEG T
Citation: N. Hunzelmann et al., DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF IFN-GAMMA FOR THE TREATMENT OF LOCALIZED SCLERODERMA, Journal of investigative dermatology, 105(3), 1995, pp. 483-483
Citation: W. Gaus et J. Hogel, STUDIES ON THE EFFICACY OF UNCONVENTIONAL THERAPIES - PROBLEMS AND DESIGNS, Arzneimittel-Forschung, 45-1(1), 1995, pp. 88-92
Authors:
PORZSOLT F
SCHMID M
HOHER D
MUCHE R
GAUS W
MONTENARH M
Citation: F. Porzsolt et al., BIOLOGIC RELEVANCE OF AUTOANTIBODIES AGAINST P53 IN PATIENTS WITH METASTATIC BREAST-CANCER, Onkologie, 17(4), 1994, pp. 402-408
Citation: M. Dietrich et al., AN INTERNATIONAL RANDOMIZED STUDY WITH LONG-TERM FOLLOW-UP OF SINGLE VERSUS COMBINATION CHEMOTHERAPY OF MULTIBACILLARY LEPROSY, Antimicrobial agents and chemotherapy, 38(10), 1994, pp. 2249-2257
Citation: J. Hogel et al., CHANGE-TO-OPEN-LABEL DESIGN - PROPOSAL AND DISCUSSION OF A NEW DESIGNFOR CLINICAL PARALLEL-GROUP DOUBLE-MASKED TRIALS, Arzneimittel-Forschung, 44-1(1), 1994, pp. 97-99
Citation: W. Gaus et M. Wiesenauer, EFFICIENCY OF A HOMEOPATHIC DRUG IN RHEUM ATOID-ARTHRITIS - DISCUSSION OF CRITICAL REMARKS AND OUTLOOK, Aktuelle Rheumatologie, 18(5), 1993, pp. 159-162
Authors:
ROZDZINSKI E
KERN WV
REICHLE A
MORITZ T
SCHMEISER T
GAUS W
KURRLE E
Citation: E. Rozdzinski et al., ONCE-DAILY VERSUS THRICE-DAILY DOSING OF NETILMICIN IN COMBINATION WITH BETA-LACTAM ANTIBIOTICS AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC PATIENTS, Journal of antimicrobial chemotherapy, 31(4), 1993, pp. 585-598
Citation: V. Mobus et al., TUMOR-MARKER COURSES FOR ASSESSING THE EF FECTIVITY OF CHEMOTHERAPY OR HORMONE-THERAPY IN METASTASIZING CARCINOMA OF THE BREAST - REPLY, Geburtshilfe und Frauenheilkunde, 53(8), 1993, pp. 588-589